Yuyong Zhou
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots.
Journal: Emerging microbes & infections
Published: October 15, 2025
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals.
Journal: Scientific reports
Published: April 16, 2024
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.
Journal: Science advances
Published: December 21, 2022
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals.
Journal: iScience
Published: April 21, 2022
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.
Journal: Antimicrobial agents and chemotherapy
Published: June 07, 2021
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2.
Journal: Scientific reports
Published: October 06, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026